Microsoft’s US$550 million sale of a massive patent portfolio to online rival Facebook is sure to draw the scrutiny of antitrust enforcers, observers say – both for the patents contained in the portfolio and the timing of the sale.
Microsoft has agreed to buy more than 800 patents from AOL for US$1.06 billion and to obtain licensing rights over 300 more, in an effort to bolster its patent pool and gain a better footing in the continuing high-tech sector patent war.
Patent-pool owner Cascades Computer Innovation has filed an antitrust suit in the US, accusing Motorola, HTC, Samsung, LG Electronics and Dell of conspiring to obtain patent licensing under better terms.
Korea’s Fair Trade Commission (KFTC) today unconditionally cleared the US$12.5 billion merger between Google and Motorola Mobility, saying that although concerns over possible patent abuse remain, these concerns are not merger-specific.
A German court has denied Motorola’s request to force Apple to stop selling some of its products on suspicion of patent infringement, saying the sales block would breach antitrust laws.
The US Department of Justice and the European Commission cleared Google’s purchase of Motorola Mobility on Monday, giving the online search leader a trove of patents and the ability to manufacture its own mobile handsets.
EU Competition Commissioner Joaquín Almunia has condemned companies’ use of patents to increase their market power and vowed to take steps to ensure markets remain competitive.
The European Commission is asking whether US technology company Google could use patents acquired in its proposed purchase of Motorola Mobility to increase the market power of its own mobile software at the expense of rivals, documents show.
A group of 11 Californian pharmacists have alleged that drug companies Pfizer and Ranbaxy Laboratories deliberately delayed the entry of a generic drug onto the market to inflate its price.
US bookseller Barnes & Noble has asked the US Department of Justice’s antitrust division to investigate whether computer software company Microsoft has used questionable patents to try to harm competition in the market for mobile operating systems.
Drug maker AstraZeneca has agreed to pay US$20 million to settle a potential class action lawsuit accusing the company of using sham patent litigation to unfairly monopolise the market for the branded heart disease medication Tropol XL.
The US Department of Justice’s antitrust division has begun an in-depth examination of why a group of the world’s largest technology companies banded together and paid a far-higher-than-expected price to buy patents targeted by online search operator Google.
The US Federal Trade Commission (FTC) has petitioned the Third Circuit Court of Appeals in support of class action plaintiffs that are challenging pay-for-delay agreements in the pharmaceutical industry.